Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation

被引:12
|
作者
Shahzad, Yasser [1 ]
Khan, Qalandar [2 ]
Hussain, Talib [1 ]
Shah, Syed Nisar Hussain [2 ]
机构
[1] Univ Huddersfield, Sch Appl Sci, Div Pharm & Pharmaceut Sci, Huddersfield HD1 3DH, W Yorkshire, England
[2] Bahauddin Zakariya Univ, Fac Pharm, Multan, Pakistan
关键词
Lornoxicam; Lotion; Design of experiment; Permeation; Flux; RELEASE MATRIX TABLETS; IN-VITRO EVALUATION; PENETRATION ENHANCEMENT; DIFFUSION; DELIVERY; DESIGN; SKIN; VALIDATION; DICLOFENAC; IBUPROFEN;
D O I
10.1016/j.ijbiomac.2013.06.049
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lornoxicam containing topically applied lotions were formulated and optimized with the aim to deliver it transdermally. The formulated lotions were evaluated for pH, viscosity and in vitro permeation studies through silicone membrane using Franz diffusion cells. Data were fitted to linear, quadratic and cubic models and best fit model was selected to investigate the influence of variables, namely hydroxypropyl methylcellulose (HPMC) and ethylene glycol (EG) on permeation of lornoxicam from topically applied lotion formulations. The best fit quadratic model revealed that low level of HPMC and intermediate level of EG in the formulation was optimum for enhancing the drug flux across silicone membrane. FTIR analysis confirmed absence of drug-polymer interactions. Selected optimized lotion formulation was then subjected to accelerated stability testing, sensatory perception testing and in vitro permeation across rabbit skin. The drug flux from the optimized lotion across rabbit skin was significantly better that that from the control formulation. Furthermore, sensatory perception test rated a higher acceptability while lotion was stable over stability testing period. Therefore, use of Box-Wilson statistical design successfully elaborated the influence of formulation variables on permeation of lornoxicam form topical formulations, thus, helped in optimization of the lotion formulation. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [1] Development and Optimization of Microemulsion Formulation using Box-Behnken Design for Enhanced Transdermal Delivery of Lornoxicam
    Naeem, Muhammad
    Rahman, Nisar Ur
    Khan, Jawad A.
    Sehti, Ayesha
    Nawaz, Zarqa
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (08): : 1196 - 1204
  • [2] Formulation optimization of a drug in adhesive transdermal analgesic patch
    Ravula, Ranadheer
    Herwadkar, Anushree K.
    Abla, Mehtab J.
    Little, John
    Banga, Ajay K.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (06) : 862 - 870
  • [3] Formulation and Evaluation of Transdermal Drug Delivery System Containing Lornoxicam.
    Prakash, Gorle Ashish
    Arun, Patil Mukesh
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (03): : 2148 - 2157
  • [4] LORNOXICAM AND FRANKINCENSE OIL TRANSDERMAL GEL: A POTENTIAL FORMULATION FOR MANAGEMENT OF INFLAMMATION
    Ranade, Sunita Y.
    Gaud, R. S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (01): : 190 - 198
  • [5] Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation
    El-Ridy, Mohamed Shafik
    Yehia, Soad Aly
    Mohsen, Amira Mohamed
    El-Awdan, Sally A.
    Darwish, Asmaa Badawy
    CURRENT DRUG DELIVERY, 2018, 15 (01) : 122 - 133
  • [6] Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers
    Li, Keke
    Gao, Shanshan
    Tian, Baocheng
    Shi, Yanan
    Lv, Qingzhi
    Han, Jingtian
    CURRENT DRUG DELIVERY, 2018, 15 (03) : 424 - 435
  • [7] Formulation, Optimization and Evaluation of Solid Lipid Nanoparticles of Lornoxicam
    Palei, Narahari N.
    Das, Malay K.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (10): : 1528 - 1537
  • [8] Influence of poly(ethylene glycol)-α-cyclodextrin complexes on stabilization and transdermal permeation of ascorbic acid
    Davaran, Soodabeh
    Hanaee, Jalal
    Rashidi, Mohammad R.
    Valiolah, Fatemeh
    Hashemi, Mahdi
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 78A (03) : 590 - 594
  • [9] Formulation and Evaluation of Chitosan Based Transdermal Patches of Lornoxicam for Prolonged Drug Release and to Study the Effect of Permeation Enhancer
    Yadav, Adhikrao Vyankatrao
    Urade, Mukund Namdeo
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2019, 53 (01) : 88 - 96
  • [10] Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery
    Gonullu, Umit
    Uner, Melike
    Yener, Gulgun
    Karaman, Ecem Fatma
    Aydogmus, Zeynep
    ACTA PHARMACEUTICA, 2015, 65 (01) : 1 - 13